Setting Sail Abroad | Clinflash Dazzles at the 2024 CRM Trial Connect Annual Meeting!

During May 9th to 10th, the 2024 CRM (Clinical Research Malaysia) Trial Connect Annual Meeting was held in Kuala Lumpur, Malaysia. Clinflash attended the conference, bringing independently developed digital solutions for clinical trials from China to international colleagues gathered from Southeast Asia.

In the conference, Clinflash's digital solutions received a lot of attention, and Dr. Dzulkefly Ahmad, Minister of Health of Malaysia, had a cordial exchange with Clinflash staff and took a group photo.

Clinflash staff took a group photo with the Minister of Health of Malaysia

The CRM Trial Connect Annual Meeting, hosted by Clinical Research Malaysia (an agency under the Ministry of Health Malaysia), aims to advance the application of high-quality clinical research solutions across Asia-Pacific and globally, creating a brighter and more hopeful future for people.

Hosting the third Southeast Asia pharmaceutical industry exchange conference, the 2024 CRM Trial Connect also collaborated with organizations such as EORTC (European Organization for Research and Treatment of Cancer) and NCC (National Cancer Center of Japan), drawing attention from clinical researchers across Asia-Pacific and Europe.

As the leader in cloud solutions and professional services for clinical research in China, Clinflash was also invited to participate in this conference, addressing several hot topics like patient rights protection and decentralized clinical research with Chinese solutions.

Clinflash made a stunning appearance at the 2024 CRM Trial Connect Annual Conference

During the conference, Dr. Dzulkefly Ahmad, Minister of Health of Malaysia, had a detailed exchange with Mr. Guan Weihua, General Manager of Clinflash, and had an in-depth understanding of Clinflash's product architecture and service system. Mr. Guan Weihua, general manager of Clinflash, together with the business team, introduced the clinical trial digital platform and professional services independently developed by Clinflash to international customers in detail, which won wide recognition from the participants.

Actually, with Clinflash’s strong capabilities in digital pharmaceutical R&D, the Clinflash systems have already been verified by several international regulatory authorities, including the FDA (U.S. Food and Drug Administration), PMDA (Japan's Pharmaceuticals and Medical Devices Agency)，NPRA (National Pharmaceutical Regulatory Agency of Malaysia), PFDA (Philippines Food and Drug Administration), and BPOM (Badan Pengawas Obatdan Makanan).

Clinflash has servers in China, the United States, France, Singapore and South Korea to efficiently meet the data security and privacy protection requirements of customers in different regions, and provide better services for local sponsors, research centers and other participants.

So far，Clinflash systems have been successfully implemented in over 30 countries and regions, supporting more than 6,000 clinical trial projects, including over 60 multi-regional clinical trials, becoming a significant force in driving global medical innovation.

Looking ahead, Clinflash will utilize more methods to deepen its engagement and cooperation with pharmaceutical enterprises from different countries and regions, steadily implementing international development strategy. With comprehensive digital solutions and professional service system, Clinflash aims to enhance the research and development productivity and efficiency of global pharmaceutical companies!